Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan

Annals of Hematology

Volumn 91, Issue 11, 2012, Pages 1773-1778

  Wu, Shang Yin ^a   Yeh, Yu Min ^a   Chen, Ya Ping ^a   Su, Wu Chou ^a   Chen, Tsai Yun ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Multiple myeloma; Taiwan; Thalidomide; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; DEXAMETHASONE; THALIDOMIDE;

ADULT; ARTERIAL THROMBOEMBOLISM; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; COHORT ANALYSIS; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; REFRACTORY PERIOD; RETROSPECTIVE STUDY; SALVAGE THERAPY; TAIWAN; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; COHORT STUDIES; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TAIWAN; THALIDOMIDE; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

EID: 84867335330     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1506-2     Document Type: Article

References (27)

1. Huang SY, Yao M, Tang JL et al (2007) Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer 110:896-905
2. Palumbo A, Sezer O, Kyle R et al (2009) International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia 23:1716-1730
3. Kumar SK, Mikhael JR, Buadi FK et al (2009) Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. Mayo Clin Proc 84:1095-1110
4. Palumbo A, Bringhen S, Caravita T et al (2006) Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomized controlled trial. Lancet 367:825-831
5. Facon T, Mary JY, Hulin C et al (2007) Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet 370:1209-1218
6. Hulin C, Facon T, Rodon P et al (2009) Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. J Clin Oncol 27:3664-3670
7. Diamopoulos MA, Anagnostopoulos A, Weber D (2003) Treatment of plasma cell dyscrasias with thalidomide and its derivatives. J Clin Oncol 21:4444-4454
8. Falanga A, Marchetti M (2009) Venous thromboembolism in the hematologic malignancies. J Clin Oncol 27:4848-4857
9. Palumbo A, Facon T, Sonneveld P et al (2008) Thalidomide for treatment of multiple myeloma: 10 years later. Blood 111:3968-3977
10. Snowden JA, Ahmedzai SH, Ashcroft J et al (2011) Guidelines for supportive care in multiple myeloma 2011. Br J Haematol 154:76-103
11. Zangari M, Anaissie E, Barlogie B et al (2001) Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 98:1614-1615
12. Palumbo A, Rajkumar SV, Dimopoulos MA et al (2008) Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma. Leukemia 22:414-423
13. White RH, Keenan CR (2009) Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 123(Suppl 4): S11-S17
14. Suzuki S, Yamashita T, Kato T et al (2007) Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation. Circ J 71:761-765
15. Chan FK, Chung SC, Suen BY et al (2001) Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344:967-973
16. Koh Y, Bang SM, Lee JH et al (2010) Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide. Ann Hematol 89:201-206
17. Palumbo A, Cavo M, Bringhen S et al (2011) Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. J Clin Oncol 29:986-993
18. Bataille R, Durie BG, Grenier J, Sany J (1986) Prognostic factor sand staging in multiple myeloma: a reappraisal. J Clin Ocnol 4:80-87
19. Chiou TJ, Wang TH, Chao TY et al (2007) Randomized phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma. Cancer Invest 25:140-147
20. Huang SY, Tang JL, Yao M et al (2003) Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma. Ann Hematol 82:558-564
21. KropffM, Giongco Baylon H, Hillengass J et al (2012) Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial. Haematologica 97:784-791
22. Dimopoulos MA, Zervas K, Kouvatseas G et al (2001) Thalidomide and dexamethasone combination for refractory multiple myeloma. Ann Oncol 12:991-995
23. Anagnostopoulos A, Weber D, Rankin K et al (2003) Thalidomide and dexamethasone for resistant multiple myeloma. Br J Haematol 121:768-771
24. Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):381S-453S
25. Weisman SM, Graham DY (2002) Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 162:2197-2202
26. Lin DB, Lin JB, Chen CY et al (2007) Seroprevalence of Helicobacter pylori infection among schoolchildren and teachers in Taiwan. Helicobacter 12:258-264
27. Libourel EJ, Sonneveld P, van der Holt B et al (2010) High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study. Blood 116:22-26